Odonate Therapeutics, Inc. (ODT)

Trade ODT now with
2/14/2018 8:19:00 AM Odonate Therapeutics Q4 Loss/shr $0.81 Vs. $0.19 Prior Year
1/2/2018 6:09:18 AM Jefferies Starts Odonate Therapeutics, Inc. (ODT) At Buy With $40 Price Target
12/28/2017 9:02:08 AM Odonate Initiates CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer